Suppr超能文献

鉴定中国遗传性多发性骨软骨瘤患者 和 基因中的新型突变。

Identification of Novel Mutations in the and Genes of Chinese Patients with Hereditary Multiple Osteochondromas.

机构信息

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Graduate Department, Bengbu Medical College, Bengbu, China.

出版信息

Genet Test Mol Biomarkers. 2021 Feb;25(2):145-151. doi: 10.1089/gtmb.2020.0098.

Abstract

To detect mutations in the and genes in four Chinese families with hereditary multiple osteochondromas (HMO). HMO is an autosomal dominant disorder characterized by the overgrowth of multiple cartilage-capped bones in the metaphysis of long bones and flat bones. Polymerase chain reaction-based amplification followed by DNA sequencing of the complete coding sequences of and was performed for four Chinese families with HMO. The mutant allele was found in six patients: three mutations were found in and two in . A novel frameshift mutation, which generates a premature stop codon at codon 586 and causes partial loss of the glycosyltransferase domain, was detected in exon 9 of EXT1 (F579Yfs8). We hypothesize that F579Yfs8 is a pathogenic mutation. Two novel missense mutations (G339S and V545D) were found in . The variant c.1634T>A (V545D) is apparently benign. In addition we found a novel deletion mutation in , c.856_864 del TTCCTCCTG, which results in the deletion of 286Phe, 287Leu, and 288Leu, that is likely pathogenic. Finally, we identified a likely benign variant in exon 13 of . c.2035-41T>C (rs3740878). We found three novel, potentially pathogenic mutations in and , including a novel frameshift mutation. More importantly, our study results have expanded the spectrum of mutations conducive to the genetic diagnosis and counseling of patients with HMO.

摘要

为了检测四个中国遗传性多发性骨软骨瘤(HMO)家系中 EXT1 和 EXT2 基因的突变。HMO 是一种常染色体显性遗传疾病,其特征是长骨和扁骨干骺端的多个软骨帽骨过度生长。对四个 HMO 中国家系进行了基于聚合酶链反应的 EXT1 和 EXT2 完整编码序列的 DNA 测序。在 6 名患者中发现了突变等位基因:在 EXT1 中发现了 3 种突变,在 EXT2 中发现了 2 种突变。在 EXT1 外显子 9 中检测到一种新的移码突变,该突变在密码子 586 产生一个提前终止密码子,并导致糖基转移酶结构域部分缺失(F579Yfs8)。我们假设 F579Yfs8 是一种致病性突变。在 EXT2 中发现了 2 种新的错义突变(G339S 和 V545D)。变体 c.1634T>A(V545D)显然是良性的。此外,我们还在 EXT2 中发现了一个新的缺失突变,c.856_864delTTCCTCCTG,导致 286Phe、287Leu 和 288Leu 的缺失,这可能是致病性的。最后,我们在 EXT2 外显子 13 中鉴定出一个可能良性的变体 c.2035-41T>C(rs3740878)。我们在 EXT1 和 EXT2 中发现了三个新的、可能具有致病性的突变,包括一个新的移码突变。更重要的是,我们的研究结果扩大了 EXT1 突变谱,有利于 HMO 患者的遗传诊断和咨询。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验